ArticlePloS one2012

The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function.

Christy M Hebner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.